Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/30/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program
(NASDAQ: TNGX) Delayed: 23.34 -1.94 (7.67%)
Previous Close $25.28    52 Week High $ 
Open $24.93    52 Week Low $ 
Day High $25.09    P/E N/A 
Day Low $23.28    EPS $ 
Volume 1,999,011